Atlantic Sapphire to delist after striking restructuring deal with major investors
What's the deal? Atlantic SapphireDealroom has a profile for this one. Try Dealroom →, a Florida-based land-based salmon farming company, has agreed a restructuring deal with a group of major shareholders and convertible loan holders. The plan will see it delist from the EuronextDealroom has a profile for this one. Try Dealroom → Oslo Børs stock exchange and come under the control of Coral HoldCo AS, a joint investment vehicle set up by its main investor group.
The deal is expected to provide at least $20M in new liquidity. It also reduces the company's debt through a partial write-down of its convertible loan, with the remaining amount converted into new shares for participating lenders.
The investor group — Condire ManagementDealroom has a profile for this one. Try Dealroom →, Nordlaks HoldingDealroom has a profile for this one. Try Dealroom →, Nokomis Capital, Strawberry CapitalDealroom has a profile for this one. Try Dealroom →, and Joh. Johannsson EiendomDealroom has a profile for this one. Try Dealroom → — represents about 63% of Atlantic Sapphire's shares and 93% of its outstanding convertible loan. Coral HoldCo will make a voluntary offer at NOK 0.80 per share ($0.086), then squeeze out remaining minority shareholders at the same price.
The restructuring also includes a private placement of up to $16M at NOK 0.10 per share, with the first $10M tranche fully underwritten by the investor group.
Why now? Atlantic Sapphire warned throughout early 2026 about its capital needs. In February 2026, it said it needed $15–$25M; by March 2026, that estimate had risen to $25–$30M. In March 2026, it secured a bridge loan of up to $10M after concerns it risked breaching its loan agreements — that loan's maturity has now been extended to August 31, 2026.
The urgency came despite reported operational improvements. The company said cash flow remained under pressure due to the timing of those gains and ongoing costs.
What could go wrong? Atlantic Sapphire itself acknowledged the restructuring does not fully cover its estimated funding needs for the 12 months ahead, nor does it fully restore its equity and liquidity to adequate levels. The company will likely need yet more capital.
The transaction also requires regulatory approval from Norway's Financial Supervisory Authority and shareholder approval at a general meeting. The board said it had considered alternatives, including a rights issue, but concluded this structure offered a fairer outcome for minority investors.
Without the deal, the board warned Atlantic Sapphire would have faced a "highly uncertain situation" for employees and "limited recovery" for creditors.
The signal: Atlantic Sapphire's retreat from public markets underscores the capital-intensity challenge facing land-based aquaculture. Despite being classified at a "breakout" growth stage on Dealroom, the company's repeated funding shortfalls — from $15–$25M in February 2026 to $25–$30M by March 2026 — reveal a widening gap between operational ambition and financial reality. The investor consortium's willingness to take it private at a fraction of prior valuations suggests continued conviction in the underlying technology, but on terms that effectively wipe out public shareholders.
Read more: weareaquaculture.com
